First published online July 23, 2007
Journal of Cell Science 120, 1501e (2007)
© The Company of Biologists Limited
Prion protection
Many neurodegenerative diseases are caused by the accumulation of insoluble protein aggregates. Transmissible spongiform encephalopathies (such as scrapie, BSE and Creutzfeldt-Jacob disease) occur when nerve cells are exposed to misfolded prion protein (PrPSc), which converts normal prion protein (PrPC) into aggregates of PrPSc. But what causes the loss of neurons – is it just the presence of PrPSc or also the lack of PrPC? Evan Eisenberg and colleagues (p. 2663) have been investigating this question in cultured human neuronal cells. The researchers manipulated PrPC levels in these cells by knocking PrPC down by RNAi or by overexpressing it by transfecting cells with a mouse prion gene. Then they examined the effects on protein aggregation by transfecting the cells with a version of the huntingtin protein that has an expanded polyglutamine tract and so is prone to aggregation. Cells lacking PrPC display increased huntingtin aggregation; in cells overexpressing PrPC, aggregation is reduced. Furthermore, the cells lacking PrPC have reduced proteosome activity, reduced activity of cellular defence enzymes and more reactive oxygen species, leading the researchers to suggest that PrPC protects cells from the toxic effects of aggregated huntingtin.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
Related articles in JCS:
- Cellular prion protein (PrPC) protects neuronal cells from the effect of huntingtin aggregation
- Kyung-Jin Lee, Antony Panzera, David Rogawski, Lois E. Greene, and Evan Eisenberg
JCS 2007 120: 2663-2671.
[Abstract]
[Full Text]